(19)
(11) EP 1 620 735 A1

(12)

(43) Date of publication:
01.02.2006 Bulletin 2006/05

(21) Application number: 04729080.4

(22) Date of filing: 23.04.2004
(51) International Patent Classification (IPC): 
G01N 33/68(1980.01)
(86) International application number:
PCT/EP2004/004350
(87) International publication number:
WO 2004/097424 (11.11.2004 Gazette 2004/46)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 25.04.2003 US 465369 P

(71) Applicants:
  • Genova Ltd.
    Hamilton HM12 (BM)
  • Novartis Pharma GmbH
    1230 Wien (AT)

    AT 

(72) Inventors:
  • BOUGUELERET, Lydie
    CH-1217 Meyrin (CH)
  • REFFAS, Samia
    CH-1217 Meyrin (CH)

(74) Representative: Leon, Susanna Iris et al
Novartis AG Corporate Intellectual Property P.O. Box
4002 Basel
4002 Basel (CH)

   


(54) SECRETED POLYPEPTIDE SPECIES REDUCED IN CARDIOVASCULAR DISORDERS